首页> 美国卫生研究院文献>Immunology >Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo.
【2h】

Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo.

机译:白细胞介素-4和白细胞介素10具有软骨保护作用可减少体内类风湿性滑膜中单核细胞的募集。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We used the severe combined immunodeficient (SCID) mouse model to assess the effect of interleukin-4 (IL-4) or IL-10 injection on cartilage degradation and mononuclear cell (MNC) recruitment to human rheumatoid synovium in vivo. Human rheumatoid synovium and cartilage from five rheumatoid arthritis patients, obtained after joint replacement surgery, were engrafted subcutaneously to 6-8-week-old SCID CB17 mice. Synovial tissues were injected with recombinant human IL-4 (rhIL-4, 100 ng; rhIL-10, 100 ng), both cytokines, or tumour necrosis factor-alpha (TNF-alpha) (1000 U), or phosphate-buffered saline twice a week for 4 weeks. The graft was removed and immunochemical analysis was carried out to assess intracellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin expression. Moreover, cartilage degradation was assessed through the quantification of the erosion surface on a computerized image of the engrafted cartilage at high power view. MNC recruitment in the synovial tissue was determined by labelling blood MNC with indium-111 before their intraperitoneal injection. The activity obtained in the region of the graft were determined with a gamma camera 72 hr postinjection. The results are expressed as a percentage of initial injected activity. After 4 weeks we observed a decrease of cartilage area in controls (77 +/- 8%), inhibited after injection of IL-4, IL-10, or both cytokines (90 +/- 3%, 89.1 +/- 4%, 89.2 +/- 5% respectively), and 57 +/- 17% after TNF-alpha injection. The % MNC activity in the graft decreased to 77 +/- 81% (NS), 9 +/- 4% (P < 0.003) and 19 +/- 6% (P < 0.007) compared with untreated synovial tissue after treatment with IL-4, IL-10, or both cytokines, respectively. Moreover, IL-10 but not IL-4 decreased the expression of ICAM-1 but not VCAM-1 or E-selectin by synovial cells. These results suggest that IL-10 and IL-4 could have chondroprotective properties, and that IL-10 but not IL-4 inhibits MNC traffic towards the synovial tissue efficiently.
机译:我们使用严重的联合免疫缺陷(SCID)小鼠模型评估白介素4(IL-4)或IL-10注射对体内软骨降解和单核细胞(MNC)募集到人类风湿性滑膜的影响。将五名类风湿性关节炎患者的关节置换手术后获得的人类风湿性滑膜和软骨皮下植入6-8周龄的SCID CB17小鼠。滑膜组织注射重组人IL-4(rhIL-4,100 ng; rhIL-10,100 ng),细胞因子或肿瘤坏死因子-α(TNF-alpha)(1000 U)或磷酸盐缓冲液每周两次,共4周。取出移植物并进行免疫化学分析以评估细胞内粘附分子-1(ICAM-1),血管细胞粘附分子-1(VCAM-1)和E-选择素表达。此外,通过在高倍视野下对植入的软骨的计算机图像上的侵蚀表面进行定量评估来评估软骨的退化。通过在腹膜内注射前用铟111标记血液MNC来确定滑膜组织中的MNC募集。在注射72小时后用伽马相机测定在移植物区域中获得的活性。结果表示为初始注射活性的百分比。 4周后,我们观察到对照组的软骨面积减少(77 +/- 8%),在注射IL-4,IL-10或两种细胞因子后均受到抑制(90 +/- 3%,89.1 +/- 4% ,分别为89.2 +/- 5%)和TNF-α注射后的57 +/- 17%。与未经治疗的滑膜组织相比,移植物中的MNC活性百分比降低至77 +/- 81%(NS),9 +/- 4%(P <0.003)和19 +/- 6%(P <0.007)。 IL-4,IL-10或两种细胞因子。此外,IL-10通过滑膜细胞降低了ICAM-1的表达,但未降低VCAM-1或E-选择素的表达。这些结果表明IL-10和IL-4可能具有软骨保护特性,并且IL-10而非IL-4有效地抑制了向滑膜组织的MNC运输。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号